Northwestern Medicine investigators have discovered that a specialized protein associated with the microtubules of a cell helps facilitate and regulate early stages of HIV infection.
An emerging cancer treatment also helps prevent cells from turning into viral factories by interfering with HIV infection processes inside the cell, according to a recent study.
A recent campus talk explored how clinical trials of HIV/AIDS drugs in developing countries in the 90s sparked a wealth of discussions about ethics in scientific investigation and barriers to healthcare access.
In partnership with the AIDS Foundation of Chicago and several Northwestern University Feinberg School of Medicine departments and centers, the Public Health Boot Camp delivers an annual week-long residential training program for HIV/AIDS community-based service providers.
Robert Riestenberg, a third-year medical student, was the first author of a recent study that evaluated statin use among people with HIV, a population at an increased risk for cardiovascular disease.
Northwestern scientists specializing in HIV and AIDS gathered to share their experiences during a panel held December 3, to commemorate World AIDS Day.
A behavioral program significantly reduced the sexual risk for HIV infection among young transgender women, according to a Northwestern Medicine clinical trial.
The National Institutes of Health has awarded an $8.8 million grant to Keep It Up!, a novel online HIV prevention program that has been shown to reduce sexually transmitted infections in gay young men by 40 percent.
Feinberg scientists are confronting significant, global challenges — from antimicrobial resistance to HIV — through collaborative, cutting-edge basic science and clinical research within the Division of Infectious Diseases.
Drugs commonly used to prevent HIV transmission from mother to child during pregnancy were not associated with a higher risk of adverse birth outcomes, according to a new study.